These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 38653790

  • 1. Exploring a repurposed candidate with dual hIDO1/hTDO2 inhibitory potential for anticancer efficacy identified through pharmacophore-based virtual screening and in vitro evaluation.
    Aboomar NM, Essam O, Hassan A, Bassiouny AR, Arafa RK.
    Sci Rep; 2024 Apr 24; 14(1):9386. PubMed ID: 38653790
    [Abstract] [Full Text] [Related]

  • 2. Structural Basis of Inhibitor Selectivity in Human Indoleamine 2,3-Dioxygenase 1 and Tryptophan Dioxygenase.
    Pham KN, Lewis-Ballester A, Yeh SR.
    J Am Chem Soc; 2019 Nov 27; 141(47):18771-18779. PubMed ID: 31682426
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors.
    Cui G, Lai F, Wang X, Chen X, Xu B.
    Eur J Med Chem; 2020 Feb 15; 188():111985. PubMed ID: 31881488
    [Abstract] [Full Text] [Related]

  • 4. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
    Sari S, Tomek P, Leung E, Reynisson J.
    Molecules; 2019 Nov 28; 24(23):. PubMed ID: 31795096
    [Abstract] [Full Text] [Related]

  • 5. Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1.
    Jiang S, Li H, Piao L, Jin Z, Liu J, Chen S, Liu LL, Shao Y, Zhong S, Wu B, Li W, Ren J, Zhang Y, Wang H, Jin R.
    Aging (Albany NY); 2020 Jun 22; 12(12):11349-11363. PubMed ID: 32568737
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 4,6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors.
    Yang L, Chen Y, He J, Njoya EM, Chen J, Liu S, Xie C, Huang W, Wang F, Wang Z, Li Y, Qian S.
    Bioorg Med Chem; 2019 Mar 15; 27(6):1087-1098. PubMed ID: 30773421
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression.
    Klar R, Michel S, Schell M, Hinterwimmer L, Zippelius A, Jaschinski F.
    Cancer Immunol Immunother; 2020 Jan 15; 69(1):57-67. PubMed ID: 31802183
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Microtubule inhibitors containing immunostimulatory agents promote cancer immunochemotherapy by inhibiting tubulin polymerization and tryptophan-2,3-dioxygenase.
    Hua S, Chen F, Gou S.
    Eur J Med Chem; 2020 Feb 01; 187():111949. PubMed ID: 31830637
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of paeoniflorin from Paeonia lactiflora pall. As an inhibitor of tryptophan 2,3-dioxygenase and assessment of its pharmacological effects on depressive mice.
    Liang X, Su T, Wu P, Dai Y, Chen Y, Wang Q, Cao C, Chen F, Wang Q, Wang S.
    J Ethnopharmacol; 2023 Dec 05; 317():116714. PubMed ID: 37315645
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
    Seegers N, van Doornmalen AM, Uitdehaag JC, de Man J, Buijsman RC, Zaman GJ.
    J Biomol Screen; 2014 Oct 05; 19(9):1266-74. PubMed ID: 24870017
    [Abstract] [Full Text] [Related]

  • 19. Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO).
    Zhang S, Guo L, Yang D, Xing Z, Li W, Kuang C, Yang Q.
    Bioorg Chem; 2020 Nov 05; 104():104348. PubMed ID: 33142415
    [Abstract] [Full Text] [Related]

  • 20. Cheminformatics analysis of indoleamine and tryptophan 2,3-dioxygenase inhibitors: A descriptor and fingerprint based machine learning approach to disclose selectivity measures.
    Irannejad H, Valipour M.
    Comput Biol Med; 2024 Sep 05; 180():108954. PubMed ID: 39094327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.